DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Andy Jassy - 1 Thos Robinson - 1 It's - 1 JP Morgan - 1 Berkshire Hathaway - 1 Business Insider's Eugene Kim - 1 Kim - 1 they've - 1
Top related locs:
Oak VillageMD Haven Florida Elgin , Illinois
Top related orgs:
CVS Health - 1 Walgreens - 1 Amazon - 1 CVS - 1 Oak Street Health - 1 Business - 1 Aetna - 1 Medical - 1

Search resuls for: "Michael Cherny"


4 mentions found


☆ Amazon, CVS, and Walgreens went all in on primary care. Their bets are bleeding money.
  + stars: | 2024-03-06 | by ( ) www.businessinsider.com   time to read: +8 min
In the past several years, Amazon, CVS Health, and Walgreens each spent billions to own primary-care companies. CVS bought Oak Street Health. Here's how the bets that Amazon, CVS, and Walgreens made are playing out. CVS is building more Oak Street clinics despite lossesAn Oak Street Health location in Elgin, Illinois during its grand opening. CVS is hoping to help Oak Street clinics get profitable quicker by driving more patients their way.
Persons: Andy Jassy, Thos Robinson, It's, JP Morgan, Berkshire Hathaway, Business Insider's Eugene Kim, Kim, they've, it's, VillageMD hasn't, Jefferies, Brian Tanquilut, Tanquilut, Lydia Ramsey, Mike Pykosz, Pykosz, Aetna, Michael Cherny Organizations: CVS Health, Walgreens, Amazon, CVS, Oak Street Health, Business, Aetna, Medical, Washington Post, Summit Health, Oak, Health Locations: Oak, VillageMD, Haven, Florida, Elgin , Illinois
☆ Buy this medical billing stock with more than 30% upside, Bank of America says
  + stars: | 2023-05-19 | by ( Alex Harring | ) www.cnbc.com   time to read: +1 min
R1 RCM can extend this year's rally following an uptick in product use, Bank of America said. Analyst Michael Cherny reiterated his buy rating and raised his price target by $3 to $22. His new price target implies the medical billing stock could rally 31.1% over the next year. The company is uniquely well-positioned for an uptick in utilization, which could cushion year-end results and full-year guidance, according to the analyst. The new multiple of price to enterprise-value-to-EBITDA is still reasonable and at a discount to the long-term average, Cherny noted.
☆ Pharmacy startups are losing their battle with giants like CVS and Walgreens
  + stars: | 2023-03-28 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +12 min
Pharmacy startups like Capsule and Truepill are crumbling in the fight against pharmacy giants. But in the past year, the pharmacy startups have begun to crumble. Plus, each chain has thousands of stores across the country, providing the convenience that the pharmacy startups seek to replicate with tech. The digital-pharmacy shakeoutAnalysts suggested that healthcare startups with pharmacy components, rather than pure-play pharmacy startups, are best positioned to succeed. Truepill CEO Sid Viswanathan TruepillBut the pharmacy startups that have attempted to offer additional services have largely shelved those efforts in recent months.
☆ Bank of America reveals the most undervalued stocks on Wall Street, including this motorcycle giant
  + stars: | 2023-02-11 | by ( Michael Bloom | ) www.cnbc.com   time to read: +6 min
CNBC Pro combed through top Bank of America research to find the most undervalued stocks on Wall Street. The firm says its base case is that the already "undervalued" stock can re-rate from current levels. In addition, Harley's management team is executing well with electric vehicle motorcycles on the horizon and burgeoning international growth opportunities. The says it sees "asymmetrical upside potential" meaning that when peers in the sector go up, KKR shares could go even higher. Remain Buy for undervalued growth and pipeline with two launches worth 5bn euros peak in 23E.
0 next >>
Total: 4